{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:49:46Z","timestamp":1792133386061,"version":"4.4.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,9,28]],"date-time":"2013-09-28T00:00:00Z","timestamp":1380326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s12020-013-0065-1","type":"journal-article","created":{"date-parts":[[2013,9,27]],"date-time":"2013-09-27T20:25:24Z","timestamp":1380313524000},"page":"279-284","source":"Crossref","is-referenced-by-count":49,"title":["Decrease in TSH levels after lactose restriction in Hashimoto\u2019s thyroiditis patients with lactose intolerance"],"prefix":"10.1007","volume":"46","author":[{"given":"Mehmet","family":"Asik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahri","family":"Gunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"Binnetoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Eroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslihan","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hacer","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"Akbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coskun","family":"Bakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz","family":"Beyazit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kubilay","family":"Ukinc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,28]]},"reference":[{"key":"65_CR1","first-page":"318","volume":"63","author":"M Rucha\u0142a","year":"2012","unstructured":"M. Rucha\u0142a, E. Szczepanek-Parulska, A. Zybek, The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption. Endocrinol. Pol. 63, 318\u2013323 (2012)","journal-title":"Endocrinol. Pol."},{"key":"65_CR2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12020-012-9814-9","volume":"43","author":"M Centanni","year":"2013","unstructured":"M. Centanni, Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches. Endocrine 43, 8\u20139 (2013)","journal-title":"Endocrine"},{"key":"65_CR3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2710.2001.00363.x","volume":"26","author":"E Vermeire","year":"2001","unstructured":"E. Vermeire, H. Hearnshaw, P. Van Royen, J. Denekens, Patient adherence to treatment: three decades of research. A comprehensive review. J. Clin. Pharm. Ther. 26, 331\u2013342 (2001)","journal-title":"J. Clin. Pharm. Ther."},{"key":"65_CR4","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1210\/jc.2009-0860","volume":"94","author":"TG Bach-Huynh","year":"2009","unstructured":"T.G. Bach-Huynh, B. Nayak, J. Loh, S. Soldin, J. Jonklaas, Timing of levothyroxine administration affects serum thyrotropin concentration. J. Clin. Endocrinol. Metab. 94, 3905\u20133912 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"65_CR5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.17925\/EE.2013.09.01.40","volume":"9","author":"P Colucci","year":"2013","unstructured":"P. Colucci, C.S. Yue, M. Ducharme, S. Benvenga, A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism. Eur. Endocrinol. 9, 40\u201347 (2013)","journal-title":"Eur. Endocrinol."},{"key":"65_CR6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/thy.2007.0222","volume":"18","author":"S Benvenga","year":"2008","unstructured":"S. Benvenga, L. Bartolone, M.A. Pappalardo, A. Russo, D. Lapa, G. Giorgianni, G. Saraceno, F. Trimarchi, Altered intestinal absorption of l-thyroxine caused by coffee. Thyroid 18, 293\u2013301 (2008)","journal-title":"Thyroid"},{"key":"65_CR7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2125.2005.02433.x","volume":"60","author":"JJ Lilja","year":"2005","unstructured":"J.J. Lilja, K. Laitinen, P.J. Neuvonen, Effects of grapefruit juice on the absorption of levothyroxine. Br. J. Clin. Pharmacol. 60, 337\u2013341 (2005)","journal-title":"Br. J. Clin. Pharmacol."},{"key":"65_CR8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.beem.2009.06.006","volume":"23","author":"L Liwanpo","year":"2009","unstructured":"L. Liwanpo, J.M. Hershman, Conditions and drugs interfering with thyroxine absorption. Best Pract. Res. Clin. Endocrinol. Metab. 23, 781\u2013792 (2009)","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"65_CR9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1210\/jc.2011-1851","volume":"97","author":"C Virili","year":"2012","unstructured":"C. Virili, G. Bassotti, M.G. Santaguida, R. Iuorio, S.C. Del Duca, V. Mercuri, A. Picarelli, P. Gargiulo, L. Gargano, M. Centanni, Atypical celiac disease as cause of increased need for thyroxine: a systematic study. J. Clin. Endocrinol. Metab. 97, 419\u2013422 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"65_CR10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0022-3468(82)80319-9","volume":"17","author":"P Puri","year":"1982","unstructured":"P. Puri, E.J. Guiney, Transient hypothyroidism associated with short gut syndrome. J. Pediatr. Surg. 17, 22\u201324 (1982)","journal-title":"J. Pediatr. Surg."},{"key":"65_CR11","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1089\/thy.2006.16.1171","volume":"16","author":"M Mu\u00f1oz-Torres","year":"2006","unstructured":"M. Mu\u00f1oz-Torres, M. Varsavsky, G. Alonso, Lactose intolerance revealed by severe resistance to treatment with levothyroxine. Thyroid 16, 1171\u20131173 (2006)","journal-title":"Thyroid"},{"key":"65_CR12","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/ajcn\/48.4.1142","volume":"48","author":"NS Scrimshaw","year":"1988","unstructured":"N.S. Scrimshaw, E.B. Murray, Prevalence of lactose maldigestion. Am. J. Clin. Nutr. 48, 1086\u20131098 (1988)","journal-title":"Am. J. Clin. Nutr."},{"key":"65_CR13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(73)93095-X","volume":"2","author":"E Tuncbilek","year":"1973","unstructured":"E. Tuncbilek, R. T\u00fcr\u00fcn, B. Say, Lactose intolerance in Turkey. Lancet 2, 151 (1973)","journal-title":"Lancet"},{"key":"65_CR14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-119-6-199309150-00009","volume":"119","author":"SJ Mandel","year":"1993","unstructured":"S.J. Mandel, G.A. Brent, P.R. Larsen, Levothyroxine therapy in patients with thyroid disease. Ann. Intern. Med. 119, 492\u2013502 (1993)","journal-title":"Ann. Intern. Med."},{"key":"65_CR15","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/gut.23.11.968","volume":"23","author":"S Ladas","year":"1982","unstructured":"S. Ladas, J. Papanikos, G. Arapakis, Lactose malabsorption in Greek adults: correlation of small bowel transit time with the severity of lactose intolerance. Gut 23, 968\u2013973 (1982)","journal-title":"Gut"},{"key":"65_CR16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/00365529409091742","volume":"29","author":"H Arola","year":"1994","unstructured":"H. Arola, Diagnosis of hypolactasia and lactose malabsorption. Scand. J. Gastroenterol. 29, 26\u201335 (1994)","journal-title":"Scand. J. Gastroenterol."},{"key":"65_CR17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.NPR.0000429894.03255.80","volume":"38","author":"SL Carter","year":"2013","unstructured":"S.L. Carter, S. Attel, The diagnosis and management of patients with lactose-intolerance. Nurse Pract. 38, 23\u201328 (2013)","journal-title":"Nurse Pract."},{"key":"65_CR18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/jcem-27-2-251","volume":"27","author":"S Reichlin","year":"1967","unstructured":"S. Reichlin, R.D. Utiger, Regulation of the pituitary-thyroid axis in man: relationship of TSH concentration to concentration of free and total thyroxine in plasma. J. Clin. Endocrinol. Metab. 27, 251\u2013255 (1967)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"65_CR19","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1542\/peds.2006-1721","volume":"118","author":"MB Heyman","year":"2006","unstructured":"M.B. Heyman, Lactose intolerance in infants, children, and adolescents. Pediatrics 118, 1279\u20131286 (2006)","journal-title":"Pediatrics"},{"key":"65_CR20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3121\/cmr.2007.738","volume":"5","author":"CL Ch\u2019ng","year":"2007","unstructured":"C.L. Ch\u2019ng, M.K. Jones, J.G. Kingham, Celiac disease and autoimmune thyroid disease. Clin. Med. Res. 5, 184\u2013192 (2007)","journal-title":"Clin. Med. Res."},{"key":"65_CR21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000084526","volume":"71","author":"V Ojetti","year":"2005","unstructured":"V. Ojetti, G. Nucera, A. Migneco, M. Gabrielli, C. Lauritano, S. Danese, M.A. Zocco, E.C. Nista, G. Cammarota, A. De Lorenzo, G. Gasbarrini, A. Gasbarrini, High prevalence of celiac disease in patients with lactose intolerance. Digestion 71, 106\u2013110 (2005)","journal-title":"Digestion"},{"key":"65_CR22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1365-2036.2008.03889.x","volume":"29","author":"P Eadala","year":"2009","unstructured":"P. Eadala, J.P. Waud, S.B. Matthews, J.T. Green, A.K. Campbell, Quantifying the \u2018hidden\u2019 lactose in drugs used for the treatment of gastrointestinal conditions. Aliment. Pharmacol. Ther. 29, 677\u2013687 (2009)","journal-title":"Aliment. Pharmacol. Ther."},{"key":"65_CR23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s12020-012-9772-2","volume":"43","author":"R Vita","year":"2013","unstructured":"R. Vita, G. Saraceno, F. Trimarchi, S. Benvenga, A novel formulation of l-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations. Endocrine 43, 154\u2013160 (2013)","journal-title":"Endocrine"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-013-0065-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-013-0065-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-013-0065-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T11:48:55Z","timestamp":1564141735000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-013-0065-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,28]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["65"],"URL":"https:\/\/doi.org\/10.1007\/s12020-013-0065-1","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,28]]}}}